Vapaliximab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Chimeric (mouse/human) |
| Target | VAP-1 |
| Clinical data | |
| ATC code | none |
| Identifiers | |
| CAS Number |
336801-86-6  N |
| ChemSpider | none |
N Y (what is this?) (verify) | |
Vapaliximab is a chimeric monoclonal antibody[1] and an immunosuppressive drug.
References
| Intracellular (initiation) |
| ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracellular (reception) |
| ||||||||||||||||||||||
| Extracellular |
| ||||||||||||||||||||||
This article is issued from Wikipedia - version of the 9/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.